Condensed Consolidated Statements of Earnings - USD ($) $ in Millions	3 Months Ended
Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Net revenues	$ 5,719	$ 5,892
Cost of sales	1,434	1,446
Excise taxes on products	956	1,073
Gross profit	3,329	3,373
Marketing, administration and research costs	572	489
Operating income	2,757	2,884
Interest and other debt expense, net	229	281
Net periodic benefit income, excluding service cost	(31)	(46)
(Income) losses from investments in equity securities	80	(34)
Loss on Cronos-related financial instruments	0	10
Earnings before income taxes	2,479	2,673
Provision for income taxes	692	714
Net earnings	$ 1,787	$ 1,959
Per share data:
Basic earnings per share (in usd per share)	$ 1.00	$ 1.08
Diluted earnings per share (in usd per share)	$ 1.00	$ 1.08

Income (Loss) from Equity Securities

No definition available.

Name:	mo_IncomeLossFromEquitySecurities
Namespace Prefix:	mo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.

+ References

No definition available.